In my model, it made sense take precautions to buy time to get vaccines and treatments. We have those now, so the cost-benefit calculation changes. Further wearing a mask is not going to help people avail themselves of them, or encourage institutions to approve existing treatments or accelerate new ones.
I’m grappling with the NNT numbers mentioned above. It’s very much worth it to me to pay $10 for fluvoxamine to say cut the duration of omicron (and perhaps probability of long covid, however small it is) by, say, ~30% (that’s my estimate). It’s even worth it for me at that price to buy enough to not have to watch friends and family suffer longer if they choose to avail themselves.
In my model, it made sense take precautions to buy time to get vaccines and treatments. We have those now, so the cost-benefit calculation changes. Further wearing a mask is not going to help people avail themselves of them, or encourage institutions to approve existing treatments or accelerate new ones.
I’m grappling with the NNT numbers mentioned above. It’s very much worth it to me to pay $10 for fluvoxamine to say cut the duration of omicron (and perhaps probability of long covid, however small it is) by, say, ~30% (that’s my estimate). It’s even worth it for me at that price to buy enough to not have to watch friends and family suffer longer if they choose to avail themselves.